Document is current
Any future updates will be listed below
-
Authors
Peng, Qianqian
Ye, Xiong
Xu, Xingyi
Song, Jinghan
Yang, Zhengfeng
Xiao, Hui
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82272645)
National Natural Science Foundation of China (82172692)
the Key Technologies R&D Program of Songjiang District, Shanghai (2024SJKJGG072)
- License Information
-
More Information
Article History
Received: 19 November 2025
Accepted: 1 March 2026
First Online: 14 March 2026
Declarations
:
: There are no competing interests.
: This study involves human participants and was conducted using FFPE tissue specimens and clinical data from lung adenocarcinoma patients treated at Shanghai General Hospital. The study protocol was approved by the Institutional Review Board of Shanghai General Hospital (Project No: 2022KY011) and the Institutional Animal Care and Use Committee (IACUC) of Shanghai General Hospital (Approval No. 2024AW060). All participants provided written informed consent to participate in the study.
